Sintx Technologies, Inc. (SINT)
USD 2.01
(-19.6%)
USD 2.01
(-19.6%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 905 Thousand USD | 126.95% |
| 2022 | -3.35 Million USD | 71.72% |
| 2021 | -11.87 Million USD | 48.54% |
| 2020 | -23.07 Million USD | -5138.21% |
| 2019 | 458 Thousand USD | 108.41% |
| 2018 | -5.44 Million USD | -324.9% |
| 2017 | 2.42 Million USD | 2396.91% |
| 2016 | 97 Thousand USD | -98.23% |
| 2015 | 5.47 Million USD | 40.89% |
| 2014 | 3.88 Million USD | -75.18% |
| 2013 | 15.64 Million USD | -11.73% |
| 2012 | 17.72 Million USD | -56.4% |
| 2011 | 40.65 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.46 Million USD | -261.77% |
| 2024 Q2 | -393 Thousand USD | 73.16% |
| 2023 Q3 | -4.3 Million USD | 39.41% |
| 2023 Q1 | -10.17 Million USD | -203.13% |
| 2023 Q2 | -7.1 Million USD | 30.2% |
| 2023 Q4 | 905 Thousand USD | 121.02% |
| 2023 FY | 905 Thousand USD | 126.95% |
| 2022 FY | -3.35 Million USD | 71.72% |
| 2022 Q4 | -3.35 Million USD | -67.23% |
| 2022 Q1 | -8.06 Million USD | 32.1% |
| 2022 Q3 | -2 Million USD | 58.33% |
| 2022 Q2 | -4.81 Million USD | 40.23% |
| 2021 Q2 | -19.98 Million USD | 5.63% |
| 2021 Q4 | -11.87 Million USD | 16.2% |
| 2021 FY | -11.87 Million USD | 48.54% |
| 2021 Q3 | -14.17 Million USD | 29.08% |
| 2021 Q1 | -21.17 Million USD | 8.23% |
| 2020 Q1 | -6.05 Million USD | -1421.62% |
| 2020 FY | -23.07 Million USD | -5138.21% |
| 2020 Q2 | -15.63 Million USD | -158.37% |
| 2020 Q4 | -23.07 Million USD | 6.51% |
| 2020 Q3 | -24.68 Million USD | -57.82% |
| 2019 Q4 | 458 Thousand USD | 197.24% |
| 2019 FY | 458 Thousand USD | 108.41% |
| 2019 Q3 | -471 Thousand USD | 15.14% |
| 2019 Q2 | -555 Thousand USD | 83.91% |
| 2019 Q1 | -3.44 Million USD | 34.65% |
| 2018 Q3 | -4.29 Million USD | 32.46% |
| 2018 Q4 | -5.27 Million USD | -22.94% |
| 2018 FY | -5.44 Million USD | -324.9% |
| 2018 Q1 | 4.1 Million USD | 69.45% |
| 2018 Q2 | -6.35 Million USD | -254.87% |
| 2017 Q3 | 1.79 Million USD | 254.64% |
| 2017 Q1 | -1.46 Million USD | -1607.22% |
| 2017 FY | 2.42 Million USD | 2396.91% |
| 2017 Q4 | 2.42 Million USD | 34.71% |
| 2017 Q2 | 507 Thousand USD | 134.68% |
| 2016 Q3 | -2.12 Million USD | -135.51% |
| 2016 Q4 | 97 Thousand USD | 104.56% |
| 2016 FY | 97 Thousand USD | -98.23% |
| 2016 Q1 | 6.84 Million USD | 25.04% |
| 2016 Q2 | 5.99 Million USD | -12.38% |
| 2015 Q4 | 5.47 Million USD | -37.14% |
| 2015 Q2 | 10.15 Million USD | 37.45% |
| 2015 Q3 | 8.7 Million USD | -14.24% |
| 2015 Q1 | 7.38 Million USD | 90.14% |
| 2015 FY | 5.47 Million USD | 40.89% |
| 2014 Q2 | 8.56 Million USD | 197.95% |
| 2014 Q3 | 12.34 Million USD | 44.08% |
| 2014 Q4 | 3.88 Million USD | -68.53% |
| 2014 FY | 3.88 Million USD | -75.18% |
| 2014 Q1 | 2.87 Million USD | -81.62% |
| 2013 Q4 | 15.64 Million USD | 51.11% |
| 2013 Q2 | 18.04 Million USD | 232.87% |
| 2013 Q1 | 5.42 Million USD | -69.42% |
| 2013 FY | 15.64 Million USD | -11.73% |
| 2013 Q3 | 10.35 Million USD | -42.62% |
| 2012 Q4 | 17.72 Million USD | 0.0% |
| 2012 FY | 17.72 Million USD | -56.4% |
| 2011 FY | 40.65 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 96.658% |
| BrainsWay Ltd. | -10.32 Million USD | 108.769% |
| Cerus Corporation | 84.35 Million USD | 98.927% |
| Envoy Medical, Inc. | -3.81 Million USD | 123.728% |
| electroCore, Inc. | -9.95 Million USD | 109.091% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 117.659% |
| IceCure Medical Ltd | -9.93 Million USD | 109.11% |
| Inogen, Inc. | -103.56 Million USD | 100.874% |
| OrthoPediatrics Corp. | -9.26 Million USD | 109.766% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 124.856% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 106.91% |
| MaxCyte, Inc. | -27.76 Million USD | 103.26% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 117.614% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 257.182% |
| Orthofix Medical Inc. | 96.44 Million USD | 99.062% |
| PAVmed Inc | 29.08 Million USD | 96.889% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 105.343% |
| RxSight, Inc. | -6.68 Million USD | 113.548% |
| Sight Sciences, Inc. | -102.71 Million USD | 100.881% |
| SI-BONE, Inc. | 5.72 Million USD | 84.181% |
| TELA Bio, Inc. | -3.94 Million USD | 122.917% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 98.421% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -157.102% |
| Acutus Medical, Inc. | 12.27 Million USD | 92.63% |
| Talis Biomedical Corporation | -57.06 Million USD | 101.586% |
| Spectral AI, Inc. | -3.5 Million USD | 125.85% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 101.884% |
| CVRx, Inc. | -59.95 Million USD | 101.509% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 54.388% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 29.166% |
| Bioventus Inc. | 372.51 Million USD | 99.757% |
| Venus Concept Inc. | 74.3 Million USD | 98.782% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 108.888% |
| LivaNova PLC | 62.53 Million USD | 98.553% |
| 908 Devices Inc. | -115.09 Million USD | 100.786% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 99.718% |
| Nemaura Medical Inc. | 9.92 Million USD | 90.882% |
| NeuroPace, Inc. | 54.33 Million USD | 98.334% |
| LENSAR, Inc. | -18.31 Million USD | 104.942% |
| Apyx Medical Corporation | -5.15 Million USD | 117.569% |
| Cutera, Inc. | 288.3 Million USD | 99.686% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 87.957% |
| BioSig Technologies, Inc. | 262 Thousand USD | -245.42% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 102.065% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 109.838% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.936% |
| Axonics, Inc. | -77.19 Million USD | 101.172% |
| Outset Medical, Inc. | 67.67 Million USD | 98.663% |
| IRIDEX Corporation | -4.28 Million USD | 121.105% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 100.508% |
| IRadimed Corporation | -47.71 Million USD | 101.897% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 129.907% |
| INVO Bioscience, Inc. | 8.45 Million USD | 89.291% |
| Telesis Bio, Inc. | 32.63 Million USD | 97.227% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 136.169% |
| Varex Imaging Corporation | 316.9 Million USD | 99.714% |
| Quipt Home Medical Corp. | 81.73 Million USD | 98.893% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 132.531% |
| Pulmonx Corporation | -42.36 Million USD | 102.136% |
| Dynatronics Corporation | 6.2 Million USD | 85.413% |
| Modular Medical, Inc. | -8.04 Million USD | 111.253% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 121.061% |
| Semler Scientific, Inc. | -57.13 Million USD | 101.584% |
| InMode Ltd. | -135.39 Million USD | 100.668% |
| Bruker Corporation | 891.3 Million USD | 99.898% |
| Cytosorbents Corporation | 4.18 Million USD | 78.36% |
| DexCom, Inc. | 2.02 Billion USD | 99.955% |
| Align Technology, Inc. | -840.47 Million USD | 100.108% |
| Viveve Medical, Inc. | -13.81 Million USD | 106.552% |
| ZimVie Inc. | 450.41 Million USD | 99.799% |
| Movano Inc. | -5.86 Million USD | 115.428% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 100.673% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 257.182% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 54.388% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 99.746% |
| Profound Medical Corp. | -18.17 Million USD | 104.978% |
| Insulet Corporation | 798.1 Million USD | 99.887% |
| enVVeno Medical Corporation | -2.21 Million USD | 140.803% |
| Surmodics, Inc. | -12.01 Million USD | 107.533% |
| iCAD, Inc. | -21.2 Million USD | 104.267% |
| Nuwellis, Inc. | -2.81 Million USD | 132.104% |
| Biotricity, Inc. | 23.09 Million USD | 96.081% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 99.034% |
| Aethlon Medical, Inc. | -4.5 Million USD | 120.104% |
| InspireMD, Inc. | -8.04 Million USD | 111.249% |
| PAVmed Inc. | 29.08 Million USD | 96.889% |
| BIOLASE, Inc. | 11.34 Million USD | 92.022% |
| Beyond Air, Inc. | 6.22 Million USD | 85.471% |
| FONAR Corporation | -14.66 Million USD | 106.171% |
| AxoGen, Inc. | 32.26 Million USD | 97.195% |
| Vivani Medical, Inc. | 42 Thousand USD | -2054.762% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 108.491% |
| Inari Medical, Inc. | -7.16 Million USD | 112.638% |
| UFP Technologies, Inc. | 40.77 Million USD | 97.78% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 70.508% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 118.968% |
| Tenon Medical, Inc. | -1.25 Million USD | 172.112% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 111.899% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 107.588% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.959% |
| NanoVibronix, Inc. | -3.27 Million USD | 127.608% |
| Quanterix Corporation | -132.95 Million USD | 100.681% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 132.531% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 104.047% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.88% |
| TransMedics Group, Inc. | 121.13 Million USD | 99.253% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 103.457% |
| NeuroMetrix, Inc. | -1.49 Million USD | 160.695% |
| Hyperfine, Inc. | -75.61 Million USD | 101.197% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 99.405% |
| Biomerica, Inc. | -3.38 Million USD | 126.736% |
| Bone Biologics Corporation | -3.02 Million USD | 129.902% |
| AVITA Medical, Inc. | -26.23 Million USD | 103.45% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 149.227% |
| Silk Road Medical, Inc | 64.42 Million USD | 98.595% |